5As and PA for Weight Loss Flashcards
What is the prevalence of obesity in Canada?
~20% and ~34% for OW
When was obesity declared a chronic disease?
CMA, 2015
What are the key components that have changed regarding obesity since 2007?
- Declaration of obesity as a chronic disease
- Impact of bias, stigma, and discrimination
- Advances in the science of obesity and weight regulation
- Advances in obesity treatments & therapies
- Recognition of patient-centered care and outcomes, beyond weight loss
How is obesity defined?
A prevalent, complex, progressive, and relapsing chronic disease characterized by abnormal or excessive body fat (adiposity) that impairs health
BMI and waist circumference can still be used as screening tools.
Previously defined by BMI (measure of size, not health).
What screening tools can be used to diagnose obesity?
- BMI
- Waist circumference
What should the diagnosis of obesity be based on?
The presence of functional, medical, and/or psychosocial impairments related to abnormal or excess body fat
What is the goal of the obesity guidelines?
To improve the standard of, and access to, care for individuals with obesity across Canada
What are the key principles of obesity management?
- Evidence-based chronic disease management principles
- Validate patients’ lived experiences
- Address root drivers of obesity
- Access to evidence-informed interventions
Which evidence-informed interventions should be included in obesity management?
- Medical nutrition therapy
- Physical activity
- Psychological interventions
- Pharmacotherapy
- Surgery
What is weight bias?
Bias and stigma faced by people living with obesity that impacts their health and access to care
How should healthcare providers address their own beliefs towards patients living with obesity?
They should assess their beliefs and attitudes and how these may influence healthcare delivery
Being aware of internalized weight bias, as well as the use of non-judgemental words, and avoiding making assumptions.
True or False: Not everyone with a large body size or high BMI has obesity.
True
What is the 5-Step (5As) Approach to Obesity Management?
- Step 1 (ASK): Recognition of obesity as a chronic disease
- Step 2 (ASSESS): Assessment of the individual (identifying root causes)
- Step 3 (ADVISE): Discussion of treatment options and adjunctive therapies
- Step 4 (AGREE): Agreement on therapy goals
- Step 5 (ASSIST): Engagement and follow-up
What is the first step in the 5-Step Approach to Obesity Management?
Recognition of obesity as a chronic disease
Asking patient’s permission to discuss obesity prior to the conversation
What should healthcare providers assess in Step 2 of the 5-Step Approach?
Root causes, complications, and barriers to obesity treatment
What are core treatment options discussed in Step 3 of the 5-Step Approach?
- Medical nutrition therapy
- Physical activity
- Psychological, pharmacological, and surgical interventions
What are the three pillars of obesity management discussed in step 3?
Psychological intervention, pharmacological therapy, bariatric surgery.
Describe the first pillar of obesity management discussed in step 3.
Psychological intervention: implementing behaviour modification, manage sleep/ time/ stress, cognitive behavioural therapy and/or acceptance therapy.
Describe the second pillar of obesity management discussed in step 3.
Pharmacological therapy: liraglutide, orlistat, naltrexone.
Criteria: BMI > 30 kg/m2 OR
BMI > 27 kg/m2 with obesity related complications
Describe the third pillar of obesity management discussed in step 3.
Bariatric surgery: Sleeve gastrectomy, gastric bypass, biliopancreatic diversion.
Criteria: BMI > 40 kg/m2 OR
BMI > 35-40 kg/m2 with obesity related complications OR
BMI > 30 kg/m2 with poorly controlled T2D
Describe step 4 and 5.
Agree and assist: agree on realistic expectations and sustainable goals (as well as an action plan). Assist in identifying drivers and barriers, while providing education and resources.
What is the Edmonton Obesity Staging System (EOSS)?
A staging tool used to classify adult obesity levels.
Describe stages 0-2 of EOSS.
Stage 0: No sign of obesity related risk factors, no symptoms, no limitations.
Stage 1: Subclinical risk factors OR mild symptoms (physical or psychological)
Stage 2: Established comorbidities OR moderate psychological symptoms or limitations
Describe stages 3-4 of EOSS.
Stage 3: Significant organ damage OR significant symptoms, limitations or imparment of well-being
Stage 4: Severe (potential end-stage) comorbidities OR severe psychological symptoms or limitations